共 50 条
- [31] Discovery of SPH3127: A Novel, Highly Potent, and Orally Active Direct Renin InhibitorJOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (16) : 10882 - 10897Iijima, DaisukeSugama, HiroshiTakahashi, YoichiHirai, MikiTogashi, YukoXie, JianshuShen, JingkangKe, YingAkatsuka, HidenoriKawaguchi, TakayukiTakedomi, KeiKashima, AkikoNishio, MasashiInui, YosukeYoneda, HikaruXia, GuangxinIijima, Toru
- [32] Discovery of novel quinoline sulphonamide derivatives as potent, selective and orally active RORγ inverse agonistsBIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (14) : 1799 - 1806Amaudrut, JeromeArgiriadi, Maria A.Barth, MartineBreinlinger, Eric C.Bressac, DidierBroqua, PierreCalderwood, David J.Chatar, MohamedCusack, Kevin P.Gauld, Stephen B.Jacquet, SebastienKamath, Rajesh, VKort, Michael E.Lepais, ValerieLuccarini, Jean-MichelMasson, PhilippeMontalbetti, ChristianMounier, LaurentPotin, DominiquePoupardin, OliviaRouaud, SylvieSpitzer, LucWallace, Craig D.
- [33] Novel pyrimidine-5-carboxylic acid as a potent and orally active PPARγ partial agonistABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 517 - 517Seto, ShigekiOkada, KyokoKiyota, Koichi
- [34] Novel Potent Selective Orally Active S1P5 Receptor AntagonistsACS MEDICINAL CHEMISTRY LETTERS, 2021, 12 (03): : 351 - 355Ma, BinGuckian, Kevin M.Liu, Xiao-gaoYang, ChunhuaLi, BingScannevin, RobertMingueneau, MichaelDrouillard, AnnabelleWalzer, Thierry
- [35] Pharmacological profile of SB939, a novel, potent and orally active histone deacetylase inhibitorEJC SUPPLEMENTS, 2006, 4 (12): : 52 - 52Sangthongpitag, K.Wu, X.Khng, H.Goh, S.Ng, P.Hu, C.Bonday, Z.Wang, H.Wood, J.Entzeroth, M.
- [36] Discovery of a novel, potent and orally active series of γ-lactams as selective NK1 antagonistsBIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (14) : 4168 - 4171Paliwal, SunilReichard, Gregory A.Shah, SapnaWrobleski, Michelle LaciWang, ChengStengone, CarmineTsui, Hon-ChungXiao, DongDuffy, Ruth A.Lachowicz, Jean E.Nomeir, Amin A.Varty, Geoffrey B.Shih, Neng-Yang
- [37] METHOXYALKYL THIAZOLES - A NOVEL SERIES OF POTENT, ORALLY ACTIVE AND ENANTIOSELECTIVE INHIBITORS OF 5-LIPOXYGENASEAGENTS AND ACTIONS, 1991, 34 (1-2): : 110 - 112MCMILLAN, RMBIRD, TGCCRAWLEY, GCEDWARDS, MPGIRODEAU, JMKINGSTON, JFFOSTER, SJ
- [38] Discovery and characterization of a novel potent, selective and orally active inhibitor for mammalian ELOVL6EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 630 (1-3) : 34 - 41Shimamura, KenNagumo, AkiraMiyamoto, YasuhisaKitazawa, HidefumiKanesaka, MakiYoshimoto, RyoAragane, KatsumiMorita, NaomiOhe, TomoyukiTakahashi, ToshiyukiNagase, TsuyoshiSato, NagaakiTokita, Shigeru
- [39] Discovery of benzoylisoindolines as a novel class of potent, selective and orally active GlyT1 inhibitorsBIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (23) : 6960 - 6965Pinard, EmmanuelAlberati, DanielaBender, MarkusBorroni, EdilioBrom, VirginieBurner, SergeFischer, HolgerHainzl, DominikHalm, RemyHauser, NicoleJolidon, SyneseLengyel, JudithMarty, Hans-PeterMeyer, ThierryMoreau, Jean-LucMory, RolandNarquizian, RobertNorcross, Roger D.Schmid, PhilippWermuth, RogerZimmerli, Daniel
- [40] NOVEL 1,2-DIARYLCYCLOPENTENES ARE SELECTIVE, POTENT, AND ORALLY-ACTIVE CYCLOOXYGENASE INHIBITORSMEDICINAL CHEMISTRY RESEARCH, 1995, 5 (05) : 351 - 363REITZ, DBLI, JJNORTON, MBREINHARD, EJHUANG, HCPENICK, MACOLLINS, JTGARLAND, DJSEIBERT, KKOBOLDT, CMGREGORY, SAVEENHUIZEN, AZHANG, YISAKSON, PC